Clinical implications and current perspectives of statin-induced rhabdomyolysis syndrome – case presentation

1 Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111–188. doi: 10.1093/eurheartj/ehz455. Erratum in: Eur Heart J. 2020 Nov 21;41(44):4255. PMID: 31504418. MachF BaigentC CatapanoAL KoskinasKC CasulaM BadimonL ChapmanMJ De BackerGG DelgadoV FerenceBA GrahamIM HallidayA LandmesserU MihaylovaB PedersenTR RiccardiG RichterDJ SabatineMS TaskinenMR TokgozogluL WiklundO ESC Scientific Document Group 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk Eur Heart J 2020 Jan 1 41 1 111 188 10.1093/eurheartj/ehz455 Erratum in: Eur Heart J. 2020 Nov 21;41(44):4255. PMID: 31504418. 31504418 Open DOISearch in Google Scholar

2 Mendes P, Robles PG, Mathur S. Statin-induced rhabdomyolysis: a comprehensive review of case reports. Physiother Can. 2014;66(2):124–132. doi:10.3138/ptc.2012-65 MendesP RoblesPG MathurS Statin-induced rhabdomyolysis: a comprehensive review of case reports Physiother Can. 2014 66 2 124 132 10.3138/ptc.2012-65400640424799748 Open DOISearch in Google Scholar

3 Ezad S, Cheema H, Collins N. Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction. Oxf Med Case Reports. 2018;2018(3):omx104. Published 2018 Mar 14. doi:10.1093/omcr/omx104 EzadS CheemaH CollinsN Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction Oxf Med Case Reports 2018 2018 3 omx104. Published 2018 Mar 14. 10.1093/omcr/omx104585300129593874 Open DOISearch in Google Scholar

4 Mohamed MFH, Salameh OK, Saeed AAM. Statin-Induced Rhabdomyolysis, Acute Kidney Injury, and Hepatitis Leading to Death. Am J Case Rep. 2019 May 18;20:709–712. doi: 10.12659/AJCR.914707. PMID: 31101801; PMCID: PMC6537756. MohamedMFH SalamehOK SaeedAAM Statin-Induced Rhabdomyolysis, Acute Kidney Injury, and Hepatitis Leading to Death Am J Case Rep. 2019 May 18 20 709 712 10.12659/AJCR.914707 PMID: 31101801; PMCID: PMC6537756. 653775631101801 Open DOISearch in Google Scholar

5 Ward NC, Watts GF, Eckel RH. Statin Toxicity. Circ Res. 2019 Jan 18;124(2):328–350. doi: 10.1161/CIRCRESAHA.118.312782. PMID: 30653440. WardNC WattsGF EckelRH Statin Toxicity Circ Res. 2019 Jan 18 124 2 328 350 10.1161/CIRCRESAHA.118.312782 PMID: 30653440. 30653440 Open DOISearch in Google Scholar

6 Sabatine MS. PCSK9 inhibitors: clinical evidence and implementation. Nat Rev Cardiol. 2019 Mar;16(3):155–165. doi: 10.1038/s41569-018-0107-8. PMID: 30420622. SabatineMS PCSK9 inhibitors: clinical evidence and implementation Nat Rev Cardiol. 2019 Mar 16 3 155 165 10.1038/s41569-018-0107-8 PMID: 30420622. 30420622 Open DOISearch in Google Scholar

7 Tobert JA, Newman CB. The nocebo effect in the context of statin intolerance. J Clin Lipidol. 2016 Jul–Aug;10(4):739–747. doi: 10.1016/j.jacl.2016.05.002. Epub 2016 May 13. PMID: 27578103. TobertJA NewmanCB The nocebo effect in the context of statin intolerance J Clin Lipidol. 2016 Jul–Aug 10 4 739 747 10.1016/j.jacl.2016.05.002 Epub 2016 May 13. PMID: 27578103. 27578103 Open DOISearch in Google Scholar

8 Mammen AL. Statin-Associated Autoimmune Myopathy. N Engl J Med. 2016 Feb 18;374(7):664–9. doi: 10.1056/NEJMra1515161. PMID: 26886523. MammenAL Statin-Associated Autoimmune Myopathy N Engl J Med. 2016 Feb 18 374 7 664 9 10.1056/NEJMra1515161 PMID: 26886523. 26886523 Open DOISearch in Google Scholar

9 Gallo A, Perregaux J, Bruckert E. Advances in the management of statin myopathy. Curr Opin Endocrinol Diabetes Obes. 2021 Apr 1;28(2):142–151. doi: 10.1097/MED.0000000000000595. PMID: 33278129 GalloA PerregauxJ BruckertE Advances in the management of statin myopathy Curr Opin Endocrinol Diabetes Obes. 2021 Apr 1 28 2 142 151 10.1097/MED.0000000000000595 PMID: 33278129 33278129 Open DOISearch in Google Scholar